Clinical trial
Controlled Study of Immunogenicity and Safety of the Investigational vYF Candidate Vaccine in Comparison to Stamaril in Adults
NCT05011123 is registered in ClinicalTrials.gov with Sanofi Pasteur, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Controlled Study of Immunogenicity and Safety of the Investigational vYF Candidate Vaccine in Comparison to Stamaril in Adults
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- October 7, 2021
- Completion date
- April 23, 2027
- Enrollment
- 690 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.